Chroma Therapeutics (WO 2005/019826 ) Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Chroma Therapeutics (WO 2005/019826 ) General Information
Description
Developer of chemically modified chromosome fragments. The asset is involved in the development made by scientists and in the detection of chemically modified chromosome fragments called nucleosomes from cancer cells circulating in the blood of cancer patients.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Drug Discovery
Acquirer
Primary Office
- 93 Innovation Drive
- Milton Park
- Abingdon OX14 4RY
- England, United Kingdom
+44 01235 000000
Chroma Therapeutics (WO 2005/019826 ) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Chroma Therapeutics (WO 2005/019826 ) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|